Education
About Us
Working with TipRanks
Follow Us
HDEF - ETF AI Analysis
Top Page
Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, such as Roche Holding AG and Iberdrola, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Low Expense Ratio
The ETF charges a very low expense ratio, making it a cost-effective choice for investors.
Geographic Diversification
The fund is spread across multiple countries, including the UK, Switzerland, and Japan, reducing reliance on any single economy.
Negative Factors
Sector Concentration in Financials
The ETF has a high allocation to the financial sector, which could make it vulnerable to downturns in that industry.
Underperforming Holding
TotalEnergies SE, one of the top 10 holdings, has shown negative year-to-date performance, which may drag on the fund's overall returns.
Limited U.S. Exposure
With only 1.12% allocated to U.S. companies, the fund may miss out on growth opportunities in the world's largest economy.
HDEF vs. SPDR S&P 500 ETF (SPY)
AUM2.23B
RegionDeveloped Markets
Expense Ratio0.09%
Beta0.41
IssuerXtrackers
Inception DateAug 12, 2015
Dividend Yield3.86%
Asset ClassEquity
Index TrackedMSCI EAFE High Dividend Yield
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume173,529
30 Day Avg. Volume132,304
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.80Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering114
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HDEF Summary
The Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF) is an investment fund that focuses on companies outside the U.S. and Canada, specifically in developed markets like Europe, Japan, and Australia. It follows the MSCI EAFE High Dividend Yield Index, which includes established companies known for paying high dividends. Some of its top holdings include well-known names like Novartis and Shell. This ETF is ideal for investors looking to diversify globally while earning steady income through dividends. However, since it focuses on international markets, its performance can be affected by global economic conditions and currency fluctuations.
How much will it cost me?The expense ratio for HDEF is 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because HDEF is passively managed, tracking an index rather than relying on active stock selection.
What would affect this ETF?HDEF could benefit from stable dividend payouts and growth in developed markets outside North America, especially if sectors like financials and healthcare, which have significant weight in the ETF, perform well. However, challenges such as rising interest rates, economic slowdowns in Europe or Asia, or regulatory changes affecting top holdings like Novartis or Shell could negatively impact returns. Diversification across sectors and regions provides some resilience, but global economic conditions remain a key factor to watch.
HDEF Top 10 Holdings
The HDEF ETF leans heavily on financials, consumer defensive stocks, and healthcare, with European giants like Roche and Novartis providing steady support thanks to their strong pipelines and solid dividend yields. Nestlé, while typically a reliable player, has been losing a bit of steam recently, and Unilever’s lagging performance is holding the fund back. Energy names like Shell and TotalEnergies offer mixed results, with valuation concerns tempering their appeal despite stable operations. Overall, the fund’s focus on developed markets outside North America provides a geographically diverse income stream, though sector concentration in financials adds a layer of risk.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | 5.83% | $129.56M | CHF278.64B | 52.12% | 73 Outperform | |
| Novartis AG | 5.36% | $119.15M | CHF220.01B | 29.42% | 80 Outperform | |
| Shell (UK) | 4.72% | $104.80M | £156.25B | 1.18% | 73 Outperform | |
| Allianz | 4.48% | $99.47M | €144.13B | 24.22% | 67 Neutral | |
| Nestlé SA | 4.48% | $99.44M | CHF190.30B | 15.42% | 71 Outperform | |
| Unilever | 3.65% | $81.01M | £103.83B | -7.73% | 72 Outperform | |
| Iberdrola | 3.59% | $79.71M | €122.61B | 37.97% | 67 Neutral | |
| TotalEnergies SE | 3.44% | $76.34M | €122.52B | -1.39% | 78 Outperform | |
| British American Tobacco | 3.33% | $73.85M | £93.92B | 46.05% | 71 Outperform | |
| Zurich Insurance Group | 2.76% | $61.41M | CHF82.13B | 22.07% | 78 Outperform |
HDEF Technical Analysis
Positive
―
Price Trends
30.50
Positive
29.94
Positive
28.88
Positive
Market Momentum
0.17
Positive
58.85
Neutral
75.29
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HDEF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 31.02, equal to the 50-day MA of 30.50, and equal to the 200-day MA of 28.88, indicating a bullish trend. The MACD of 0.17 indicates Positive momentum. The RSI at 58.85 is Neutral, neither overbought nor oversold. The STOCH value of 75.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HDEF.
HDEF Peer Comparison
Comparison Results
Performance Comparison
HDEF
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
31.16
7.13
29.67%
IDV
iShares International Select Dividend ETF
―
―
―
DIVI
Franklin LibertyQ International Equity Hedged ETF
―
―
―
DTH
WisdomTree International High Dividend Fund
―
―
―
FIDI
Fidelity International High Dividend ETF
―
―
―
EFAS
Global X MSCI SuperDividend EAFE ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents